Nuclear Medicine Unit, Department of Medical-Surgical Sciences and of Translational Medicine, Faculty of Medicine and Psychology, "Sapienza" University of Rome, 00185 Rome, Italy.
Biomolecules. 2023 Aug 12;13(8):1241. doi: 10.3390/biom13081241.
Following previously published systematic reviews on the diagnostic use of nanoparticles (NPs), in this manuscript, we report published methods for radiolabeling nanoparticles with therapeutic alpha-emitting, beta-emitting, or Auger's electron-emitting isotopes. After analyzing 234 papers, we found that different methods were used with the same isotope and the same type of nanoparticle. The most common type of nanoparticles used are the PLGA and PAMAM nanoparticles, and the most commonly used therapeutic isotope is Lu. Regarding labeling methods, the direct encapsulation of the isotope resulted in the most reliable and reproducible technique. Radiolabeled nanoparticles show promising results in metastatic breast and lung cancer, although this field of research needs more clinical studies, mainly on the comparison of nanoparticles with chemotherapy.
在之前关于纳米粒子(NPs)诊断用途的系统综述之后,在本文中,我们报告了用治疗性发射α粒子、β粒子或俄歇电子的同位素对纳米粒子进行放射性标记的已发表方法。在分析了 234 篇论文后,我们发现相同的同位素和相同类型的纳米粒子使用了不同的方法。使用最常见的纳米粒子类型是 PLGA 和 PAMAM 纳米粒子,最常用的治疗性同位素是 Lu。关于标记方法,直接包封同位素是最可靠和可重复的技术。放射性标记的纳米粒子在转移性乳腺癌和肺癌中显示出有希望的结果,尽管这一研究领域需要更多的临床研究,主要是比较纳米粒子与化疗。